CYP2E1 and glioblastoma: More importantly, phenotype observation of CYP2E1 gene knockout rats for 36 weeks showed that global Cyp2e1‐knockout rats did not suffer from any life‐threatening or life‐shortening conditions, suggesting that CYP2E1 as a GBM target has a good safety.